Navigation Links
Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
Date:8/29/2012

PHILADELPHIA, Aug. 29, 2012 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA), the top Democratic Appropriator for neuroscience and federal science agencies, announces that the University of Pennsylvania, Drexel University and The Children's Hospital of Philadelphia (CHOP) will receive 20 grants totaling $10,777,491 for scientific and medical research projects.

"The grants to these nationally recognized institutions in our renowned University City district in West Philadelphia will enable them to continue cutting-edge research in neuroscience, medicine, other scientific endeavors and the Internet," Fattah said. "I'm proud to be leading the fight in Congress to keep our nation Number One in the world in science, technology, research and innovation."

These latest awards have been issued by the National Science Foundation (NSF) and the Department of Health and Human Services through its National Institutes of Health (NIH). 

Fattah, Congressional champion for neuroscience, brain injury and brain disease research, announced that Penn will receive $2,126,161 for a Schizophrenia study while CHOP will get $557,262 to study obesity in adolescents with Down Syndrome, both from NIH. Fattah authored legislation last winter that raises the national priority for neuroscience research and coordinates it through the White House Office of Science and Technology Policy.

Among other grants Fattah announced today, Drexel will receive $1,080,445 from the National Science Foundation for a project entitled "TTP: Medium: Securing the Wireless Philadelphia Network." Penn will receive an NIH grant for $495,317 to study medication in black men with hypertension.

Overall, NSF's latest round of grants total more than $4 million -- five awards to Drexel for $2,073,135 and five awards to Penn for $1,938,694.

The National Institutes of Health is directing ten new grants to University City worth more than $6.7 million – eight awards to Penn for $5,514,109 and two awards to The Children's Hospital of Philadelphia for $1,251,553.

Fattah is the senior Democrat on the House Appropriations Committee's Subcommittee on Commerce, Justice, Science and related agencies, which oversees appropriations for the National Science Foundation, NOAA, NASA and the White House Office of Science and Technology Policy as well as the Departments of Commerce and Justice.


'/>"/>
SOURCE Office of Congressman Chaka Fattah
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Regeneron Announces September 2012 Investor Conference Presentations
2. Proacta Incorporated Announces IND Allowance for PR610
3. Tribogenics Announces Dual-Energy X-ray Source for XRF
4. Eaton Scientific Announces Clinical Trial Plans for Tropine 3 - Company to Seek FDA Approval as Novel Prescription Drug for Non-Hormonal Treatment of Hot Flashes in Menopausal Women
5. Cynosure Announces Upcoming Conference Presentations
6. Aragon Pharmaceuticals Announces Appointment of Faheem Hasnain as Independent Director
7. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
8. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
9. Par Pharmaceutical Companies Announces The Expiration Of The "Go Shop" Period, Receipt Of Early Termination Of HSR Waiting Period And Special Meeting Date
10. InterMune Announces Presentations of New Research in IPF at ERS
11. MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):